Growth Strategies Built on Superior Data Analytics
Data analytics is a cornerstone of all Back Bay assignments. Using a comprehensive range of data sources and the highly skilled analytic capabilities of the Back Bay team, we ensure our recommendations are always well supported and defensible.
Back Bay is an expert in the development of bespoke forecasting models and databases that are designed for the needs of the client, the nature of the project and the eventual audiences for the output. In addition, we build robust and client-ready deliverables that ensure models continue to evolve as new data becomes available, and that can be used long after the engagement ends.
This robust technical, clinical, commercial and transactional analysis enables us to create clarity out of ambiguity and serves as the foundation for well-informed growth strategies for our clients.
Look to Back Bay experts for:
Product & market opportunity assessments
Scientific, clinical & commercial due diligence
Landscapes & whitespace/gap analysis development of market & product forecast models
Commercial & financial modeling
Valuation & deal comparables analysis
Patient journey, patient flow mapping & buying process intelligence
Marketing & promotional efforts
Performance tracking
Robust Data Analysis for Biotech, Pharmaceutical and MedTech
Navigating pathways for an emerging Medtech company
An emerging MedTech company required definition of the pathway to successful commercialization & revenue opportunity for its novel skin grafting technology.APPROACH
- Our team segmented the market by both hospital (size, geography) and surgeon (burn, plastic, general) characteristics
- We described the value proposition for the client’s technology and likely positioning within each key segment
- We defined the “buying process” for driving adoption by hospitals – including administrator, procurement, surgeon perspectives and roles in the purchasing decision
- We developed a procedure-based revenue forecast for initial application and relevant adjacencies
RESULT
Our client had clarity on key requirements for facilitating surgeon and hospital adoption. Back Bay's recommendations resulted in our client transitioning from “technical” to “functional” messaging around its technology.
Valuation support for negotiations
A US academic institution required valuation support for negotiations around buy-out of multiple royalty streams related to Schizophrenia and Depression Assets.APPROACH
- We developed a robust and sensitized valuation of the institution’s relevant IP portfolio
- Our valuation comprised multiple scenarios particularly related to the potential out-licensing of the assets to a third party, which had critical implications to the value given the substantial sublicensing provision in the current agreement
- We detailed risks related to deal timing
- Our team delivered recommendations around the optimal positioning, key drivers and value inflection points for the portfolio
RESULT
Back Bay's analysis informed our client’s discussions with the license holder of the IP and set expectations for a deal pre- and post-commercialization of the related assets.